- Open Access
Neurological prognostication after cardiac arrest: how the “Best CPC” project would overcome selection biases
Critical Care volume 23, Article number: 246 (2019)
Despite perpetual improvement in post cardiac arrest (CA) care, a substantial number of patients with CA remain comatose after rewarming from targeted temperature management (TTM) and sedation discontinuation. Many patients in this situation eventually die, usually after withdrawal of life-sustaining treatment (WLST) due to a poor neurological prognosis [1, 2]. Neuroprognostication after cardiac arrest relies on a multimodal approach in which clinical examination, neurophysiological tools (electroencephalogram, somatosensory evoked potentials), biomarkers (neuron-specific enolase and S-100β) and brain imaging (computed tomography scan and magnetic resonance imaging) can be used in various combination for which the input mode is a confirmed postanoxic comatose state [3, 4].
However, these clinical and ancillary tests recommended in guidelines for neuroprognostication after CA were chiefly validated in retrospective studies of heterogeneous patient populations  potentially responsible for selection biases.
Neuroprognostication in post-anoxic coma aims chiefly to identify those patients likely to have a poor neurological prognosis, i.e., a Cerebral Performance Category (CPC) score of 3 to 5 or a modified Rankin Scale score of 3 to 6, as opposed to a CPC score of 1–2 or a modified Rankin Scale score of 0 to 2 . However, there is an important heterogeneity in these patients. Indeed, CPC scores of 3 and 4 are straightforward, as they indicate neurologic impairments due to anoxia. A CPC score of 5, i.e., death, in contrast, is not necessarily related directly to irreversible brain damage from anoxic encephalopathy. Other causes of death include post-cardiac arrest syndrome with multi-organ failure, acute respiratory distress syndrome, sepsis, high comorbidities leading to treatment-limitation decisions and recurrent CA with or without awakening. Failure to differentiate these non-neurological causes of death may result in major interpretation bias studies focused on neurological prognostication, leading to inappropriate conclusions about the predictive value of neuroprognostic tests (e.g. electroencephalogram findings) and about the impact of treatments on neurological outcomes.
Optimal neuroprognostication following CA would be performed, if it were possible, in a homogeneous population of patients remaining comatose after TTM management and after sedation was discontinued. Predictors of unfavourable outcome could be defined in such a population sub-set. Indeed, current guidelines recommend initiating neurological prognostication in patients with persistent coma 72 h after the CA, with the intent of not including those subsets of patients who will die early of multi-organ failure, or those that rapidly progress towards brain death. In an ancillary study of a TTM trial , Dragancea et al. found that the reason for WLST was neurological impairments in 85% of patients who required prognostication . However, 18% of WLST decisions were based on ethical reasons or severe comorbidities. Recently Witten et al. suggested classifying causes of death after CA as WLST for neurological reasons, WLST due to comorbidities, refractory shock, recurrent CA and respiratory failure . Among patients who died after out-of-hospital CA, 73% had their life-support withdrawn for neurological reasons. Inter-rater variability in the assessment of causes of death was noted, and some patients had more than one cause of death, chiefly for life-support withdrawal due to comorbidities or haemodynamic impairment. The broad range of conditions in comatose patients after CA may have resulted in biases in the development of the currently used neuroprognostication tools. Consequently, to improve neuroprognostication, predicting unfavourable neurological outcome should be limited to patients persistent in a comatose state beyond 72 h, a consequence of arrest-induced hypoxia-ischemia.
Conversely, predicting a favourable neurological outcome after CA would involve predicting the ability to awaken independent of final outcome, even if the patient secondarily dies. Patients with non-neurological aetiology of death prior to weaning off sedation that precludes examination of arousal should not be included in such studies either. The best daily CPC score proposed by Taccone et al. may help to assess predictors of awakening and a significant rate of late awakeners was recently reported [10,11,12]. Furthermore, in the study by Taccone et al., standard neuroprognostication criteria including electroencephalogram findings, somatosensory evoked potentials, and neurospecific enolase levels were not associated with poor neurological outcomes in patients with death after awakening . According to this strategy, the prediction of a favourable outcome would allow identifying patients that will awaken in the ICU after cardiac arrest. This category of patients who awaken would henceforth be managed as any other critical care patient and be subject to the same ICU complications and medical outcomes, as well as be subject to the discussions of end-of-life and withdrawal of care as dictated by clinical course and family considerations. Thus, in case of favourable neurological outcome prediction, we propose to focus the problem in evaluating the ability of awakening regardless of final survival status.
We recognise the limitations to our proposals. Firstly, our strategy of focusing the metric upon the favourable measure of awakening regardless of ultimate outcome will carry a bias in the over-representation of predicted final survivors, but the dividend would be that such evaluation might improve diagnostic accuracy of neuroprognostication tools. Secondly, we fully acknowledge that our proposals require confirmation via formal prospective evaluation before the “BEST CPC” concept can make a positive impact on post CA clinical care.
In conclusion, currently used neuroprognostication tools may lack diagnostic accuracy because they were developed and validated in heterogeneous populations of patients, including patients who remained continuously comatose, patients who awakened before dying, and patients erroneously classified as having died of neurological causes. Focusing on awakening and thus using the best daily CPC score may prove helpful for assessing neuroprognostication tools intended for comatose patients after CA.
Availability of data and materials
Cerebral Performance Category
Death after awakening
Targeted temperature management
Withdrawal of life-sustaining treatment
Lemiale V, Dumas F, Mongardon N, Giovanetti O, Charpentier J, Chiche J-D, et al. Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort. Intensive Care Med. 2013;39:1972–80.
Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004;30:2126–8.
Taccone FS, Cronberg T, Friberg H, Greer D, Horn J, Oddo M, et al. How to assess prognosis after cardiac arrest and therapeutic hypothermia. Crit Care. 2014;18:202.
Sandroni C, Cariou A, Cavallaro F, Cronberg T, Friberg H, Hoedemaekers C, et al. Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1816–31.
Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VRM, Deakin CD, et al. European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care. Intensive Care Med. 2015;41(12):2039–56.
Kirstie H, Laura W, Nadkarni Vinay M, Felix A, Stefanie B, Böttiger Bernd W, et al. COSCA (Core Outcome Set for Cardiac Arrest) in Adults: An Advisory Statement From the International Liaison Committee on Resuscitation. Circulation. 2018;137:e783–801.
Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013;369:2197–206.
Dragancea I, Wise MP, Al-Subaie N, Cranshaw J, Friberg H, Glover G, et al. Protocol-driven neurological prognostication and withdrawal of life-sustaining therapy after cardiac arrest and targeted temperature management. Resuscitation. 2017;117:50–7.
Witten L, Gardner R, Holmberg MJ, Wiberg S, Moskowitz A, Mehta S, et al. Reasons for death in patients successfully resuscitated from out-of-hospital and in-hospital cardiac arrest. Resuscitation. 2019;136:93–9.
Paul M, Bougouin W, Geri G, Dumas F, Champigneulle B, Legriel S, et al. Delayed awakening after cardiac arrest: prevalence and risk factors in the Parisian registry. Intensive Care Med. 2016;42:1128–36.
Rey A, Rossetti AO, Miroz J-P, Eckert P, Oddo M. Late awakening in survivors of postanoxic coma: early neurophysiologic predictors and association with ICU and long-term neurologic recovery. Crit Care Med. 2019;47(1):85–92.
Paul M, Bougouin W, Dumas F, Geri G, Champigneulle B, Guillemet L, et al. Comparison of two sedation regimens during targeted temperature management after cardiac arrest. Resuscitation. 2018;128:204–210
Taccone FS, Horn J, Storm C, Cariou A, Sandroni C, Friberg H, et al. Death after awakening from post-anoxic coma: the “Best CPC” project. Crit Care. 2019;23:107.
We thank the Centre Hospitalier de Versailles for editorial assistance and A. Wolfe, MD, for helping to prepare the manuscript.
There was no funding for the development or writing of this commentary.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1186/s13054-019-2405-x
About this article
Cite this article
Paul, M., Legriel, S. Neurological prognostication after cardiac arrest: how the “Best CPC” project would overcome selection biases. Crit Care 23, 246 (2019). https://doi.org/10.1186/s13054-019-2533-3